Sasebo Chuo Hospital

Futó vizsgálatok

• Toboroz

  Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

  NCT07286058· 3. fázis· Takeda· Forrás

• Fut, nem toboroz

  A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)

  NCT07176390· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

  NCT06671496· 3. fázis· Takeda· Forrás

• Toboroz

  A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

  NCT06747949· 3. fázis· Amgen· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis

  NCT06878404· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

  NCT06807424· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Nipocalimab in Moderate to Severe Sjogren's Disease

  NCT06741969· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

  NCT06245408· 3. fázis· Amgen· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Arthritis psoriatica1 toboroz
• Pikkelysömör1 toboroz
• Sjögren-szindróma1 toboroz

Lezárt vizsgálatok

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

  NCT06104124· 3. fázis· Amgen· Forrás

• Lezárult

  Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

  NCT05814627· 3. fázis· AbbVie· Forrás

• Lezárult

  A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

  NCT05523167· 2/3. fázis· argenx· Forrás

• Lezárult

  Study to Assess Change in Disease Activity and Adverse Events of RINVOQ in Adult Participants With Ankylosing Spondylitis in the Real-World Japan

  NCT05609643· AbbVie· Forrás

• Lezárult

  A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan

  NCT04459507· Janssen Pharmaceutical K.K.· Forrás

• Lezárult

  Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets

  NCT04340115· AbbVie· Forrás

• Lezárult

  A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis

  NCT04169373· 3. fázis· AbbVie· Forrás

• Lezárult

  Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

  NCT03025308· 3. fázis· Alfasigma S.p.A.· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• ANCA-asszociált vasculitis6 munka · 0 vizsgálat